UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3670-3681

2012

Volltextzugriff (PDF)

Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.1831-1842

2011

Volltextzugriff (PDF)

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.600-607

2011

Volltextzugriff (PDF)

Distinct Mutation Pathways of Non-Subtype B HIV-1 during In Vitro Resistance Selection with Nonnucleoside Reverse Transcriptase Inhibitors

Antimicrobial Agents and Chemotherapy, 2010-11, Vol.54 (11), p.4812-4824

2010

Volltextzugriff (PDF)

Resistance Studies of a Dithiazol Analogue, DBPR110, as a Potential Hepatitis C Virus NS5A Inhibitor in Replicon Systems

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.723-733

2013

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1403-1413

2011

Volltextzugriff (PDF)

Selection of Clinically Relevant Protease Inhibitor-Resistant Viruses Using the Genotype 2a Hepatitis C Virus Infection System

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2197-2205

2011

Volltextzugriff (PDF)

Replicative Fitness Costs of Nonnucleoside Reverse Transcriptase Inhibitor Drug Resistance Mutations on HIV Subtype C

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2146-2153

2011

Volltextzugriff (PDF)

Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

Antimicrobial Agents and Chemotherapy, 2009-10, Vol.53 (10), p.4522-4524

2009

Volltextzugriff (PDF)

Phytosphingosine-1-Phosphate Is a Signaling Molecule Involved in Miconazole Resistance in Sessile Candida albicans Cells

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2290-2294

2012

Volltextzugriff (PDF)

Bioluminescence-Based Neuraminidase Inhibition Assay for Monitoring Influenza Virus Drug Susceptibility in Clinical Specimens

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5209-5215

2013

Volltextzugriff (PDF)

Antiviral Activity and In Vitro Mutation Development Pathways of MK-6186, a Novel Nonnucleoside Reverse Transcriptase Inhibitor

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3324-3335

2012

Volltextzugriff (PDF)

ADS-J1 Inhibits HIV-1 Entry by Interacting with gp120 and Does Not Block Fusion-Active gp41 Core Formation

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4487-4492

2010

Volltextzugriff (PDF)

Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2054-2060

2011

Volltextzugriff (PDF)

Novel Method for Simultaneous Quantification of Phenotypic Resistance to Maturation, Protease, Reverse Transcriptase, and Integrase HIV Inhibitors Based on 3'Gag(p2/p7/p1/p6)/ PR/RT/INT-Recombinant Viruses: a Useful Tool in the Multitarget Era of Antiretroviral Therapy

Antimicrobial agents and chemotherapy, 2011-08, Vol.55 (8), p.3729-3742

2011

Volltextzugriff (PDF)

The Base Component of 3′-Azido-2′,3′-Dideoxynucleosides Influences Resistance Mutations Selected in HIV-1 Reverse Transcriptase

Antimicrobial Agents and Chemotherapy, 2011-08, Vol.55 (8), p.3758-3764

2011

Volltextzugriff (PDF)

Inhibition of Human Immunodeficiency Virus Type 1 by Triciribine Involves the Accessory Protein Nef

Antimicrobial Agents and Chemotherapy, 2010-04, Vol.54 (4), p.1512-1519

2010

Volltextzugriff (PDF)

Iatrogenic Cushing's Syndrome Induced by Posaconazole

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5727-5728

2013

Volltextzugriff (PDF)

Potencies of Newer Fluoroquinolones against Viridans Group Streptococci Isolated in 637 Cases of Bloodstream Infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada

Antimicrobial agents and chemotherapy, 2000-10, Vol.44 (10), p.2922-2923

2000

Volltextzugriff (PDF)

Novel Pseudo-Staphylococcal Cassette Chromosome mec Element (ΨSCCmec57395) in Methicillin-Resistant Staphylococcus pseudintermedius CC45

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5509-5515

2013

Volltextzugriff (PDF)

High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure

Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1273-1280

2012

Volltextzugriff (PDF)

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3538-3545

2011

Volltextzugriff (PDF)

Prevalence of Colistin Resistance Gene mcr-1 and Absence of mcr-2 in Escherichia coli Isolated from Healthy Food-Producing Animals in Japan

Antimicrobial agents and chemotherapy, 2017-01, Vol.61 (1)

2017

Volltextzugriff (PDF)

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2654-2663

2013

Volltextzugriff (PDF)

Evaluation of Reduced Susceptibility to Quaternary Ammonium Compounds and Bisbiguanides in Clinical Isolates and Laboratory-Generated Mutants of Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3488-3497

2013

Volltextzugriff (PDF)

1 – 25 von 1.764

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAntimicrobial Agents And Chemotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.762)
Mit Volltextzugriff
(1.759)

Publikationsform

Artikel
(1.764)

Sprache

Englisch
(1.764)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Microbiology
(1.656)
Life Sciences & Biomedicine
(1.653)
Pharmacology & Pharmacy
(1.653)
Science & Technology
(1.653)
Biological And Medical Sciences
(1.430)
Medical Sciences
(1.396)
Pharmacology. Drug Treatments
(1.382)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(1.379)
Infectious Diseases
(1.141)
Humans
(1.081)
Microbial Sensitivity Tests
(811)
Anti-Bacterial Agents - Pharmacology
(653)
Bacterial Diseases
(599)
Human Bacterial Diseases
(597)
Anti-Bacterial Agents
(596)
Animals
(566)
Mechanisms Of Resistance
(521)
Staphylococcal Infections, Streptococcal Infections, Pneumococcal Infections
(406)
Female
(376)
Staphylococcus Aureus
(363)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(1.762)
MEDLINE
(1.723)

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir

Combinatorial Approaches to the Prevention and Treatment of HIV-1 Infection

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

Distinct Mutation Pathways of Non-Subtype B HIV-1 during In Vitro Resistance Selection with Nonnucleoside Reverse Transcriptase Inhibitors

Resistance Studies of a Dithiazol Analogue, DBPR110, as a Potential Hepatitis C Virus NS5A Inhibitor in Replicon Systems

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides

Selection of Clinically Relevant Protease Inhibitor-Resistant Viruses Using the Genotype 2a Hepatitis C Virus Infection System

Replicative Fitness Costs of Nonnucleoside Reverse Transcriptase Inhibitor Drug Resistance Mutations on HIV Subtype C

Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

Phytosphingosine-1-Phosphate Is a Signaling Molecule Involved in Miconazole Resistance in Sessile Candida albicans Cells

Bioluminescence-Based Neuraminidase Inhibition Assay for Monitoring Influenza Virus Drug Susceptibility in Clinical Specimens

Antiviral Activity and In Vitro Mutation Development Pathways of MK-6186, a Novel Nonnucleoside Reverse Transcriptase Inhibitor

ADS-J1 Inhibits HIV-1 Entry by Interacting with gp120 and Does Not Block Fusion-Active gp41 Core Formation

Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase

Novel Method for Simultaneous Quantification of Phenotypic Resistance to Maturation, Protease, Reverse Transcriptase, and Integrase HIV Inhibitors Based on 3'Gag(p2/p7/p1/p6)/ PR/RT/INT-Recombinant Viruses: a Useful Tool in the Multitarget Era of Antiretroviral Therapy

The Base Component of 3′-Azido-2′,3′-Dideoxynucleosides Influences Resistance Mutations Selected in HIV-1 Reverse Transcriptase

Inhibition of Human Immunodeficiency Virus Type 1 by Triciribine Involves the Accessory Protein Nef

Iatrogenic Cushing's Syndrome Induced by Posaconazole

Potencies of Newer Fluoroquinolones against Viridans Group Streptococci Isolated in 637 Cases of Bloodstream Infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada

Novel Pseudo-Staphylococcal Cassette Chromosome mec Element (ΨSCCmec57395) in Methicillin-Resistant Staphylococcus pseudintermedius CC45

High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

Prevalence of Colistin Resistance Gene mcr-1 and Absence of mcr-2 in Escherichia coli Isolated from Healthy Food-Producing Animals in Japan

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness

Evaluation of Reduced Susceptibility to Quaternary Ammonium Compounds and Bisbiguanides in Clinical Isolates and Laboratory-Generated Mutants of Staphylococcus aureus

Aktive Filter

Suchergebnisse filtern